EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease-Reference-Cited by-同舟云学术

EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease

Published:2017-06-13 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Thieme Karina,Majumder Syamantak,Brijmohan Angela S.,Batchu Sri N.,Bowskill Bridgit B.,Alghamdi Tamadher A.,Advani Suzanne L.,Kabir M. Golam,Liu Youan,Advani Andrew

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-03237-3.pdf

Reference49 articles.

1. Cybulsky, A. V. Cyclooxygenases, prostanoids, and glomerular injury: complex relationships. Journal of the American Society of Nephrology: JASN 18, 367–368 (2007).

2. Cheng, H. et al. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. Journal of the American Society of Nephrology: JASN 18, 551–559 (2007).

3. Cheng, H. et al. Distinct roles for basal and induced COX-2 in podocyte injury. Journal of the American Society of Nephrology: JASN 20, 1953–1962 (2009).

4. Cheng, H., Fan, X., Moeckel, G. W. & Harris, R. C. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. Journal of the American Society of Nephrology: JASN 22, 1240–1251 (2011).

5. Vogt, L., de Zeeuw, D., Woittiez, A. J. & Navis, G. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 24, 1182–1189 (2009).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue lipidomic profiling supports a mechanistic role of the prostaglandin E2 pathway for albuminuria development in glomerular hyperfiltration;Frontiers in Network Physiology;2023-12-22

2. Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E ₂ Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria;Hypertension;2023-04

3. CD248 induces a maladaptive unfolded protein response in diabetic kidney disease;Kidney International;2023-02

4. The histologic disorders and underlying mechanisms of podocytes during diabetes;Diabetic Nephropathy;2022-12-01

5. Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor;PROSTAG OTH LIPID M;2022